Administrative Core
行政核心
基本信息
- 批准号:10646339
- 负责人:
- 金额:$ 16.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAccountingAddressAnimal ExperimentationAnimalsAtrial FibrillationAwarenessBackBasic ScienceBiologicalCell modelCellsClinicClinicalCollaborationsCommunicationDataDocumentationElectrophysiology (science)EnsureEnvironmentExperimental DesignsFundingGenerationsGenesGeneticGenomicsGoalsGrantHeart AtriumHumanHuman Subject ResearchInformation DisseminationLeadershipLinkMaintenanceManuscriptsMentorsMetabolismMonitorMusNational Heart, Lung, and Blood InstituteOffice of Administrative ManagementOralParticipantPerformancePharmaceutical PreparationsPhenotypePreparationPreventiveProgress ReportsReportingReproducibilityResearchResearch PersonnelResourcesScheduleScienceScientistServicesSystems BiologyTherapeuticTimeTranslatingVisitWorkWritingcardiac tissue engineeringdesignexperimental studygene interactiongenome wide association studyhuman subjectmeetingsmouse modeloperationprofessional atmosphereprofessorprogramsresponsible research conductsexsynergism
项目摘要
ADMINISTRATIVE CORE (AC)
PROJECT/SUMMARY ABSTRACT
The overall goals of the Administrative Core (AC) are to provide organizational, administrative, fiscal,
communication, and reporting support to each Project and Core within the Program Project (P01), entitled
"Atrial Fibrillation Post-GWAS: Mechanisms to Treatment." Our overall theme is to translate AF genomic
discoveries back to the bedside, focusing on genes to mechanisms, genes to drugs, and interactions of
genes with metabolism and environment. In conjunction with the Executive Committee (EC), consisting of
the Program Director, Project Leads and Core Directors, the AC will promote collaboration and synergy for
all P01 components; centrally monitor and evaluate their performance; and facilitate interactions with the
Internal Advisory Board (IAB) and External Advisory Board (EAB). The AC will promote integration,
efficiency of resource use, and organizational and administrative support. The AC will be essential in
coordinating all communications and reviewing all activities among all Projects and all Cores. Importantly,
the AC will work closely with the EC and Cores to coordinate generation, maintenance, and experimental
use of human cell and mouse models that will optimize experimental design, use of these resources, and
integration of all Projects and Cores to efficiently accelerate the Program towards completion of its goals.
The aims of the Core are to: 1) Promote collaboration and integration of the Program by providing
organizational and administrative support; 2) Facilitate scientific exchange, dissemination of results, and
communications; 3) Evaluate and promote research progress; 4) Provide managerial and fiscal grant
management; and 5) Ensure and monitor best practices, resource utilization and coordination. The Core will
promote best practices for rigor and responsibility, animal and human subjects research, responsible
conduct of research, and mentoring and coaching of early stage investigators. The AC will monitor
Projects and Scientific Cores and assure that sex as a biological variable has been addressed. In
summary, the Administrative Core will function to unify and coordinate activities amongst the Program
Project participants. It will facilitate organizational and administrative management of the Program,
provide centralized access and coordination for cell and mouse experiment planning, and enhance
significance, scope and scale of the projects. The services of this core do not replicate efforts of
established cores at Cleveland Clinic, making this core uniquely designed to support P01 investigators.
行政核心 (AC)
项目/摘要摘要
行政核心 (AC) 的总体目标是提供组织、行政、财政、
项目项目 (P01) 内每个项目和核心的沟通和报告支持,题为
“GWAS 后的心房颤动:治疗机制。”我们的总体主题是翻译 AF 基因组
发现回到床边,重点关注基因到机制、基因到药物以及相互作用
基因与新陈代谢和环境有关。与执行委员会 (EC) 一起,由以下人员组成:
项目总监、项目负责人和核心总监,审计委员会将促进以下方面的合作和协同作用:
所有 P01 组件;集中监控和评估他们的表现;并促进与
内部顾问委员会 (IAB) 和外部顾问委员会 (EAB)。审计委员会将促进一体化,
资源利用效率以及组织和行政支持。交流电至关重要
协调所有项目和所有核心之间的所有沟通并审查所有活动。重要的是,
AC 将与 EC 和核心密切合作,协调发电、维护和实验
使用人类细胞和小鼠模型来优化实验设计、这些资源的使用,以及
整合所有项目和核心,以有效加速该计划实现其目标。
核心的目标是: 1) 通过提供
组织和行政支持; 2) 促进科学交流、成果传播,以及
通讯; 3)评估和推动研究进展; 4) 提供管理和财政补助
管理; 5) 确保和监控最佳实践、资源利用和协调。核心将
促进严谨和责任、动物和人类受试者研究的最佳实践,负责任
进行研究,并对早期研究人员进行指导和指导。空调将监控
项目和科学核心并确保性别作为生物变量得到解决。在
总之,行政核心将负责统一和协调该计划之间的活动
项目参与者。它将促进该计划的组织和行政管理,
为细胞和小鼠实验计划提供集中访问和协调,并增强
项目的重要性、范围和规模。该核心的服务不会复制
在克利夫兰诊所建立了核心,使该核心的设计独特,以支持 P01 研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mina Kay Chung其他文献
Mina Kay Chung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mina Kay Chung', 18)}}的其他基金
Atrial Fibrillation Post-GWAS: Mechanisms to Treatment
GWAS 后心房颤动:治疗机制
- 批准号:
10410643 - 财政年份:2022
- 资助金额:
$ 16.1万 - 项目类别:
Atrial Fibrillation Post-GWAS: Mechanisms to Treatment
GWAS 后心房颤动:治疗机制
- 批准号:
10646338 - 财政年份:2022
- 资助金额:
$ 16.1万 - 项目类别:
Project 3 Genes to Omics-Informed Drugs: Drug Repositioning and Testing to Prevent AF Progressions
项目 3 基因组学药物:药物重新定位和测试以预防 AF 进展
- 批准号:
10410650 - 财政年份:2022
- 资助金额:
$ 16.1万 - 项目类别:
Project 3 Genes to Omics-Informed Drugs: Drug Repositioning and Testing to Prevent AF Progressions
项目 3 基因组学药物:药物重新定位和测试以预防 AF 进展
- 批准号:
10646374 - 财政年份:2022
- 资助金额:
$ 16.1万 - 项目类别:
相似国自然基金
套期会计有效性的研究:实证检验及影响机制
- 批准号:72302225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
上市公司所得税会计信息公开披露的经济后果研究——基于“会计利润与所得税费用调整过程”披露的检验
- 批准号:72372025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
- 批准号:72302197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332003
- 批准年份:2023
- 资助金额:166 万元
- 项目类别:重点项目
相似海外基金
3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
3/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
- 批准号:
10711001 - 财政年份:2023
- 资助金额:
$ 16.1万 - 项目类别:
Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
为 MedStar Health 接受肺癌筛查的患者提供烟草治疗:一项随机试验
- 批准号:
10654115 - 财政年份:2023
- 资助金额:
$ 16.1万 - 项目类别:
Sensitivity to Cannabis Effects and Cue Reactivity as Markers of a Developing Disorder in Adolescents
对大麻效应的敏感性和提示反应性作为青少年发育障碍的标志
- 批准号:
10586397 - 财政年份:2023
- 资助金额:
$ 16.1万 - 项目类别:
2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
2/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
- 批准号:
10711336 - 财政年份:2023
- 资助金额:
$ 16.1万 - 项目类别:
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.
唐氏综合症患者脑血管疾病的无创生物识别筛查。
- 批准号:
10816240 - 财政年份:2023
- 资助金额:
$ 16.1万 - 项目类别: